Zhejiang Cheng Yi Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 653.25 million compared to CNY 693.45 million a year ago. Revenue was CNY 654.97 million compared to CNY 693.96 million a year ago.

Net income was CNY 161.58 million compared to CNY 170.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.4929 compared to CNY 0.5214 a year ago. Diluted earnings per share from continuing operations was CNY 0.4929 compared to CNY 0.5214 a year ago.